Literature DB >> 25848485

Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.

Ki Tae Suk1, Dong Joon Kim1.   

Abstract

Liver fibrosis is a common histological change of chronic liver injury and it is closely related with portal hypertension which is hemodynamic complication of chronic liver disease. Currently, liver fibrosis has been known as a reversible dynamic process in previous literatures. Although liver biopsy is a gold standard for assessing the stage of liver fibrosis, it may not completely represent the stage of liver fibrosis because of sampling error or semi-quantative measurement. Recent evidences suggested that histologic, clinical, hemodynamic, and biologic features are closely associated in patients with chronic liver disease. Hepatic venous pressure gradient (HVPG) measurement has been known as a modality to evaluate the portal pressure. The HVPG measurement has been used clinically for fibrosis diagnosis, risk stratification, preoperative screening for liver resection, monitoring the efficacy of medical treatments, and assessing the prognosis of liver fibrosis. Therefore, the HVPG measurement can be used to monitor areas the chronic liver disease but also other important areas of chronic liver disease.

Entities:  

Keywords:  Fibrosis; Liver; Venous pressure

Year:  2015        PMID: 25848485      PMCID: PMC4381184          DOI: 10.4254/wjh.v7.i3.607

Source DB:  PubMed          Journal:  World J Hepatol


  94 in total

Review 1.  Gastroesophageal variceal hemorrhage.

Authors:  A I Sharara; D C Rockey
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.

Authors:  Francesco Vizzutti; Umberto Arena; Roberto G Romanelli; Luigi Rega; Marco Foschi; Stefano Colagrande; Antonio Petrarca; Stefania Moscarella; Giacomo Belli; Anna Linda Zignego; Fabio Marra; Giacomo Laffi; Massimo Pinzani
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

3.  Reversibility of liver fibrosis.

Authors:  David A Brenner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-11

4.  Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.

Authors:  Jose A Carrión; Miquel Navasa; Jaume Bosch; Miquel Bruguera; Rosa Gilabert; Xavier Forns
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

5.  Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.

Authors:  Diego Rincón; Oreste Lo Iacono; Marta Tejedor; Ana Hernando; Cristina Ripoll; María-Vega Catalina; Magdalena Salcedo; Ana Matilla; María Senosiain; Gerardo Clemente; Luis-Miguel Molinero; Agustín Albillos; Rafael Bañares
Journal:  Scand J Gastroenterol       Date:  2012-08-08       Impact factor: 2.423

Review 6.  Role of Kupffer cells in host defense and liver disease.

Authors:  Manfred Bilzer; Frigga Roggel; Alexander L Gerbes
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

Review 7.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

8.  Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation.

Authors:  Alejandro Blasco; Xavier Forns; José A Carrión; Juan Carlos García-Pagán; Rosa Gilabert; Antoni Rimola; Rosa Miquel; Miquel Bruguera; Juan-Carlos García-Valdecasas; Jaime Bosch; Miquel Navasa
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

9.  Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.

Authors:  Càndid Villanueva; Carles Aracil; Alan Colomo; Virginia Hernández-Gea; Josep M López-Balaguer; Cristina Alvarez-Urturi; Xavier Torras; Joaquim Balanzó; Carlos Guarner
Journal:  Gastroenterology       Date:  2009-04-01       Impact factor: 22.682

10.  Intraoperative portal venous pressure and long-term outcome after curative resection for hepatocellular carcinoma.

Authors:  M Hidaka; M Takatsuki; A Soyama; T Tanaka; I Muraoka; T Hara; T Kuroki; T Kanematsu; S Eguchi
Journal:  Br J Surg       Date:  2012-09       Impact factor: 6.939

View more
  22 in total

1.  Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients.

Authors:  Ai Nakagawa; Masanori Atsukawa; Akihito Tsubota; Chisa Kondo; Tomomi Okubo; Taeang Arai; Norio Itokawa; Yoshiyuki Narahara; Katsuhiko Iwakiri
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

2.  Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension.

Authors:  Noelle H Ebel; Kristen Carlin; Michele L Shaffer; Giri Shivaram; Matthew Hawkins; Erin R Lane; Kara Cooper; Will S Lindquester; Gaurav Gadodia; Karen F Murray
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-06       Impact factor: 2.839

3.  Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018.

Authors:  Daniel R Ludwig; Tyler J Fraum; Roberto Cannella; David H Ballard; Richard Tsai; Muhammad Naeem; Maverick LeBlanc; Amber Salter; Allan Tsung; Anup S Shetty; Amir A Borhani; Alessandro Furlan; Kathryn J Fowler
Journal:  Abdom Radiol (NY)       Date:  2019-06

4.  Second-harmonic generation (SHG) microscopy and hepatic venous pressure gradient-based validation of a novel histological staging system for alcoholic hepatitis.

Authors:  Archana Rastogi; Nayana Patil; Rakhi Maiwall; Chhagan Bihari; Ananda Soshee; Shiv K Sarin
Journal:  Virchows Arch       Date:  2021-04-02       Impact factor: 4.064

Review 5.  Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease.

Authors:  Gashaw Hassen; Abhishek Singh; Gizeshwork Belete; Nidhi Jain; Ivonne De la Hoz; Genesis P Camacho-Leon; Nitsuh K Dargie; Keila G Carrera; Tadesse Alemu; Sharan Jhaveri; Nebiyou Solomon
Journal:  Cureus       Date:  2022-05-30

Review 6.  The Use of Transient Elastography Technology in the Bariatric Patient: a Review of the Literature.

Authors:  Max M Puthenpura; Vishal Patel; John Fam; Leon Katz; David S Tichansky; Stephan Myers
Journal:  Obes Surg       Date:  2020-09-26       Impact factor: 4.129

7.  Developmental programming: Metabolic tissue-specific changes in endoplasmic reticulum stress, mitochondrial oxidative and telomere length status induced by prenatal testosterone excess in the female sheep.

Authors:  Muraly Puttabyatappa; Joseph N Ciarelli; Adam G Chatoff; Vasantha Padmanabhan
Journal:  Mol Cell Endocrinol       Date:  2021-02-17       Impact factor: 4.102

Review 8.  Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis.

Authors:  Shu Dong; Qi-Long Chen; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-28       Impact factor: 2.629

9.  Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.

Authors:  Hai Li; Hong You; Xu Fan; Jidong Jia
Journal:  BMJ Open Gastroenterol       Date:  2016-05-25

10.  The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease.

Authors:  Yvonne Alt; Anna Grimm; Liesa Schlegel; Annette Grambihler; Jens M Kittner; Jörg Wiltink; Peter R Galle; Marcus A Wörns; Jörn M Schattenberg
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.